Foghorn Therapeutics (FHTX) Debt Ratio (2019 - 2021)

Foghorn Therapeutics' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.11 for Q3 2021.

• On a quarterly basis, Debt Ratio rose 3.06% year-over-year to 0.11 in Q3 2021; TTM through Sep 2021 was 0.11, a 3.06% increase from a year earlier, with the FY2020 full-year figure at 0.08, down 88.63% from the prior year.
• Debt Ratio climbed to 0.11 in Q3 2021 per FHTX's latest filing, from 0.1 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.68 in Q4 2019 and bottomed at 0.08 in Q4 2020.
• The 3-year median for Debt Ratio is 0.1 (2021), against an average of 0.19.
• Across the five-year window, Debt Ratio sank 88.63% in 2020 and rose 3.06% in 2021, its largest moves.
• Year by year, Debt Ratio stood at 0.68 in 2019, then slumped by 88.63% to 0.08 in 2020, then jumped by 39.18% to 0.11 in 2021.
• Per Business Quant, the three latest FHTX Debt Ratio figures stand at 0.11 (Q3 2021), 0.1 (Q2 2021), and 0.09 (Q1 2021).